Pfizer’s Q1 Update May Mark A Bottom In The Stock (NYSE:PFE)

This article was written by Follow Providing alpha-generating investment ideas. I am an independent investor managing…

Pfizer Stock: Best-In-Class Dividend Yield Together With Dirt Cheap Valuation (NYSE:PFE)

This article was written by Follow As an investor who started my path five years ago…

Pfizer (PFE): Looks Better Than Most, But I Can’t Eat Relative Returns (NYSE:PFE)

This article was written by Follow I’m Rob Isbitts, founder of Sungarden Investment Publishing. I run…